Patents by Inventor Kumar Rajesh

Kumar Rajesh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEM ON A CHIP WITH AN INTEGRATED CONFIGURABLE SAFETY MASTER MICROCONTROLLER UNIT
    Publication number: 20230205672
    Abstract: A system on a chip (SoC) includes a first domain comprising a first processor configured to boot the SoC, and a first debug subsystem, a second domain comprising a second processor, the second domain configurable as either a safety domain or a general-purpose processing domain, and isolation circuitry between the first domain and the second domain. During boot-up of the SoC, the first processor provides code to the second domain which, when executed by the second processor, configures the second domain as either a safety domain or as a general-purpose processing domain.
    Type: Application
    Filed: March 3, 2022
    Publication date: June 29, 2023
    Inventors: Venkateswar Kowkutla, Raghavendra Santhanagopal, Chunhua Hu, Anthony Frederick Seely, Nishanth Menon, Vanga Kumar Rajesh, Rejitha Nair, Siva Srinivas Kothamasu, Kazunobu Shin, Jason Peck, John Apostol
  • Ocular tear growth factor-like protein
    Patent number: 7459440
    Abstract: The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: December 2, 2008
    Assignee: University of Virginia Patent Foundation
    Inventors: Gordon W. Laurie, Sandhya Sanghi, Kumar Rajesh, Angela J. Lumsden
  • Ocular tear growth factor-like protein
    Patent number: 7320870
    Abstract: The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: January 22, 2008
    Assignee: University of Virginia Patent Foundation
    Inventors: Gordon W. Laurie, Sandhya Sanghi, Kumar Rajesh, Angela J. Lumsden
  • Ocular tear growth factor-like protein
    Publication number: 20070167371
    Abstract: The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
    Type: Application
    Filed: March 6, 2007
    Publication date: July 19, 2007
    Inventors: Gordon Laurie, Sandhya Sanghi, Kumar Rajesh, Angela Lumsden
  • Ocular tear growth factor-like protein
    Publication number: 20070167372
    Abstract: The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
    Type: Application
    Filed: March 6, 2007
    Publication date: July 19, 2007
    Inventors: Gordon Laurie, Sandhya Sanghi, Kumar Rajesh, Angela Lumsden
  • Ocular tear growth factor-like protein
    Publication number: 20040081984
    Abstract: The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
    Type: Application
    Filed: August 19, 2003
    Publication date: April 29, 2004
    Inventors: Gordon W. Laurie, Sandhya Sanghi, Kumar Rajesh, Angela J. Lumsden